- Home
- IPST vs RLYB Comparison
IPST vs RLYB Comparison
Compare IPST & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPST
- RLYB
- Stock Information
- Founded
- IPST 2011
- RLYB 2018
- Country
- IPST United States
- RLYB United States
- Employees
- IPST N/A
- RLYB N/A
- Industry
- IPST Beverages (Production/Distribution)
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- IPST Consumer Staples
- RLYB Health Care
- Exchange
- IPST Nasdaq
- RLYB Nasdaq
- Market Cap
- IPST 22.0M
- RLYB 24.1M
- IPO Year
- IPST 2024
- RLYB 2021
- Fundamental
- Price
- IPST N/A
- RLYB $0.56
- Analyst Decision
- IPST
- RLYB Hold
- Analyst Count
- IPST 0
- RLYB 2
- Target Price
- IPST N/A
- RLYB N/A
- AVG Volume (30 Days)
- IPST 4.8M
- RLYB 318.4K
- Earning Date
- IPST 08-14-2025
- RLYB 11-06-2025
- Dividend Yield
- IPST N/A
- RLYB N/A
- EPS Growth
- IPST N/A
- RLYB N/A
- EPS
- IPST N/A
- RLYB N/A
- Revenue
- IPST $7,058,550.00
- RLYB $761,000.00
- Revenue This Year
- IPST N/A
- RLYB N/A
- Revenue Next Year
- IPST N/A
- RLYB N/A
- P/E Ratio
- IPST N/A
- RLYB N/A
- Revenue Growth
- IPST N/A
- RLYB 154.51
- 52 Week Low
- IPST $0.27
- RLYB $0.22
- 52 Week High
- IPST $4.00
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- IPST N/A
- RLYB 46.56
- Support Level
- IPST N/A
- RLYB $0.50
- Resistance Level
- IPST N/A
- RLYB $0.65
- Average True Range (ATR)
- IPST 0.00
- RLYB 0.04
- MACD
- IPST 0.00
- RLYB -0.01
- Stochastic Oscillator
- IPST 0.00
- RLYB 37.24
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.